Figure 12.K‐M analysis of recurrence and metastasis using a Mito‐Signature in a larger group of all breast cancer patients, independently of treatment. Patients with high‐expression levels of the Mito‐Signature showed near 2‐fold increases in recurrence (N = 3,951; p < 1e‐16) and distant metastasis (N = 1,746; p = 3.8e‐08).
